TABLE 2.
Strain | Antiseptic selectiona | MIC (μg/ml) |
Antibiotic susceptibility pattern (MIC [μg/ml])b | ST | Gene name | SNPc | Amino acid change | Gene function | |
---|---|---|---|---|---|---|---|---|---|
Polyhex | Chlorhex | ||||||||
COL | 0.5 | 2 | Penr, Oxar, ACr, Cefr, Vans (1.5), Tei (1.5), Dap (0.5) | 250 | |||||
COL P3 | Polyhex | 2 | 2 | Penr, Oxar, ACr, Cefr, Vanr (3), Teir (3), Dapr (3) | 250 | mprF | C1010T | L337S | Phosphatidylglycerol lysyltransferase |
COL P5 | Polyhex | 4 | 2 | Penr, Oxar, ACr, Cefr, Teir (4), Dapr (4) | 250 | mprF | C1010T | L337S | Phosphatidylglycerol lysyltransferase |
134947 | 1 | 4 | Penr, Oxar, ACr, Cefr, Cipr, Clir, Eryr | 228 | |||||
134947 P6 | Polyhex | 8 | 4 | Penr, Oxar, ACr, Cefr, Cipr, Clir, Eryr, Dapr (1.5–2) | 228 | purR | T686G | V229G | Pur operon repressor |
mprF | C884T | S295L | Phosphatidylglycerol lysyltransferase | ||||||
128822 | 1 | 8 | Penr, Oxar, ACr, Cefr, Cipr, Clir, Eryr, Genr | 228 | |||||
128822 P6 | Polyhex | 1 | 8 | Penr, Oxar, ACr, Cefr, Cipr, Clir, Eryr, Genr | 228 | NDd | |||
COL | 0.5 | 2 | Penr, Oxar, ACr, Cefr | 250 | |||||
COL P10 | Chlorhex | 0.5 | 8 | Penr, Oxar, ACr, Cefr, Cipr (D17) | 250 | T to A | Intergenic region (position 775770) between SACOLSACOL_RS03870 and NorA | ||
G to A | Intergenic region (position 814686) between SACOL_RS04065 and NrdL | ||||||||
T to A | Intergenic region (position 1227842) upstream SACOL_RS06240 | ||||||||
G to A | Intergenic region (position 1227910) upstream SACOL_RS06245SACOL_RS06245 | ||||||||
COL P7 | Chlorhex | 0.5 | 8 | Penr, Oxar, ACr, Cefr | 250 | mepA | C127T | T376I | Multidrug export protein MepA |
purR | G403T | V135F | Pur operon repressor | ||||||
134947 | 1 | 4 | Penr, Oxar, ACr, Cefr, Cipr, Clir, Eryr | 228 | |||||
134947 P10 | Chlorhex | 1 | 8 | Penr, Oxar, ACr, Cefr, Cipr, Clir, Eryr | 228 | ND | |||
128822 | 1 | 8 | Penr, Oxar, ACr, Cefr, Cipr, Clir, Eryr, Genr | 228 | |||||
128822 P10 | Chlorhex | 1 | 8 | Penr, Oxar, ACr, Cefr, Cipr, Clir, Eryr, Genr, Dapr (2) | 228 | pldB | G89T | G30V | Lysophospholipase L2 |
glpD | C293A | T98K | Aerobic glycerol-3-phosphate dehydrogenase | ||||||
mprF | C1001T | P334L | Phosphatidylglycerol lysyltransferase |
Polyhex, polyhexanide; Chlorhex, chlorhexidine.
Antibiotic susceptibility was measured by disc diffusion assays for all antibiotics except vancomycin, teicoplanin, and daptomycin (D corresponds to diameter size measurement; EUCAST ciprofloxacin susceptible diameter = 19–20). For vancomycin, teicoplanin, and daptomycin, MIC values were determined by Etest assays. EUCAST susceptibility breakpoints for are ≤2 μg/ml for vancomycin, ≤2 μg/ml for teicoplanin, and ≤1 μg/ml for daptomycin. Changes in antibiotic resistance patterns compared to those in wild-type strains are indicated by bold type. Pen, penicillin; Oxa, oxacillin; AC, amoxicillin-clavulanate; Cef, cefoxitine; Cip, ciprofloxacin; Cli, clindamycin; Ery, erythromycin; Gen, gentamicin; Van, vancomycin; Tei, teicoplanin; Dap, daptomycin; r, resistant; s, susceptible.
SNP, single-nucleotide polymorphism.
ND, not determined.